Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have recently gained attention for treating multiple medical conditions, including potential to treat IIH
Prior authorization Finally, TRICARE requires your healthcare provider to complete a prior authorization form for Wegovy
Originally designed to treat type II diabetes, the FDA approved semaglutide for weight loss in 2021
Many women notice: Bloating Slower digestion Feeling like food sits differently Appetite dysregulation tied to gut discomfort All of this creates the perfect storm for increased cravings and weight gain, even when nothing about your habits has changed
This does not mean these items must be avoided entirely, but many patients report needing smaller portions or slower eating paces to stay comfortable
However, you will still need to complete the virtual consultation